IMPLANET, based near Bordeaux, France, with a subsidiary in Boston, focuses on spine and knee products. Their flagship product, Jazz™, is a latest generation implant that improves the treatment of spinal disorders requiring spinal fusion surgery. Jazz™ has obtained regulatory clearances in the United States and Europe. IMPLANET's marketing team identifies products and services based on detailed analysis of socio-economic, regulatory, demographic, and cultural specifications. Their R&D team focuses on scientifically and clinically proven implant designs using high-quality materials. The company collaborates closely with surgeons, engineers, and product managers to offer implants that meet the requirements of healthcare professionals. IMPLANET aims to provide Gold Standard implants of uncompromising quality while contributing to reducing healthcare costs. They operate in the commercialization of orthopedic implants segment and derive most of their revenue from France.